FCER2 and B-cell chronic lymphocytic leukemia: There were 57 (44.9%) atypical CLL cases and 34 (26.8%) CD5 negative or CD23 negative CLL cases in this study, whereas CD43 negative or CD180 negative CLL cases were only 14 (11.0%).